205.5636 Drug Management Review Advisory Board -- Membership -- Officers -- Meetings.
Loading PDF...
shall consist of sixteen (16) members to be appointed by the secretary of the
Cabinet for Health and Family Services and shall be constituted as follows:
(a) Five (5) members shall be physicians, one (1) each from the fields of family medicine, internal medicine, pediatrics, and geriatrics. The fifth physician
appointed shall be from any other recognized field of medicine. Two (2) of the
above indicated physicians shall be representatives of the two (2) current
medical schools in the Commonwealth, the University of Kentucky and the
University of Louisville Schools of Medicine; (b) Five (5) members shall be pharmacists, at least one (1) of whom shall be designated as the representative of the University of Kentucky College of
Pharmacy; (c) Two (2) members shall be advanced practice registered nurses;
(d) One (1) member shall be an optometrist and one (1) member shall be a physician's assistant; (e) One (1) member shall be a representative of the Cabinet for Health and Family Services designated to serve on an ex officio basis; and (f) One (1) nonvoting member shall be a member of the pharmaceutical manufacturing industry. (2) (a) The physician members of the board shall be appointed from a list of three (3) qualified physicians for each vacancy submitted by the Kentucky Medical
Association. (b) The pharmacist members of the board shall be appointed from a list of three (3) qualified pharmacists for each vacancy submitted by the Kentucky
Pharmacy Association. (c) The advanced practice registered nurse members of the board shall be appointed from a list of three (3) for each vacancy, submitted by the Kentucky
Nurses Association. (d) The optometrist shall be appointed from a list of three (3) qualified optometrists submitted by the Kentucky Optometric Association. (e) The physician's assistant shall be appointed from a list of three (3) qualified physicians assistants submitted by the Kentucky Board of Medical Licensure. (3) The secretary may appoint one (1) nonvoting industry representative to be selected from a list of three (3) members nominated from the Pharmaceutical Research and
Manufacturers of America. The secretary may request additional names for
appointments and current members may be considered for reappointment. All
members of the board shall be licensed and actively practicing in their respective
professions in the Commonwealth and shall have knowledge or expertise in at least
one (1) of the following areas: Page 2 of 2 (a) The clinically appropriate prescribing, utilization, and evaluation of pharmaceuticals; (b) The clinically appropriate dispensing and monitoring of pharmaceuticals;
(c) Drug utilization review, pharmacoeconomic and pharmacoepidemiological evaluation and intervention, pharmacotherapeutic intervention methods in
disease management using treatment algorithms, critical paths, and other
measures that have been well defined and validated; and (d) Medical quality assurance. (4) Three (3) of the initially appointed physician members, three (3) of the initially appointed pharmacist members, and one (1) of the initially appointed advanced
practice registered nurses shall be appointed for a term of one (1) year. The
remaining initial members shall be appointed for a term of two (2) years.
Subsequent appointments shall be for a term of two (2) years. Members shall serve
for no more than three (3) consecutive terms. The board shall designate a chair and
vice chair. A member shall serve no more than two (2) consecutive terms as chair. (5) The first meeting of the board shall take place within thirty (30) days of the appointment of all the members of the board. (6) The board shall meet at least quarterly, or upon the call of the chair or the commissioner. A majority of the voting members of the board shall constitute a
quorum. All meetings shall be conducted in accordance with the provisions of the
Open Meetings Act, KRS 61.805 to 61.850, and all balloting shall take place by roll
call vote. (7) Actions of the board shall require a majority vote of the members present or participating through distance communication technology. No member may vote on
a matter where a conflict of interest may exist. The chair may vote on any matter
before the board unless a conflict of interest exists. Effective: July 15, 2010
History: Amended 2010 Ky. Acts ch. 85, sec. 35, effective July 15, 2010. -- Amended 2005 Ky. Acts ch. 99, sec. 238, effective June 20, 2005. -- Created 1998 Ky. Acts
ch. 561, sec. 4, effective July 15, 1998.